Yan N - Search Results

1

The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD.

Li C, Liu W, Li X, Zhang Z, Qi H, Liu S, Yan N, Xing Y, Hölscher C, Wang Z. Li C, et al. Among authors: yan n. Brain Behav. 2020 Mar;10(3):e01505. doi: 10.1002/brb3.1505. Epub 2020 Jan 20. Brain Behav. 2020. PMID: 31960630 Free PMC article.

2

Junctophilin-2 allosterically interacts with ryanodine receptor type 2 to regulate calcium release units in mouse cardiomyocytes.

Luo T, Yan N, Xu M, Dong F, Liang Q, Xing Y, Fan H. Luo T, et al. Among authors: yan n. Gen Physiol Biophys. 2022 Mar;41(2):133-140. doi: 10.4149/gpb_2022007. Gen Physiol Biophys. 2022. PMID: 35416176

3

CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p.

Li M, Wang Q, Zhang X, Yan N, Li X. Li M, et al. Among authors: yan n. Cell Cycle. 2021 Jul;20(13):1279-1294. doi: 10.1080/15384101.2021.1934625. Epub 2021 Jun 7. Cell Cycle. 2021. PMID: 34097560 Free PMC article.

4

The MORN domain of Junctophilin2 regulates functional interactions with small-conductance Ca²⁺ -activated potassium channel subtype2 (SK2).

Luo T, Li L, Peng Y, Xie R, Yan N, Fan H, Zhang Q. Luo T, et al. Among authors: yan n. Biofactors. 2021 Jan;47(1):69-79. doi: 10.1002/biof.1608. Epub 2020 Jan 6. Biofactors. 2021. PMID: 31904168

5

Activity of ceritinib in crizotinib-resistant ROS1-rearranged non-small-cell lung cancer patients.

Zhang H, Li X, Zhang Z, Huang S, Guo Q, Yan N. Zhang H, et al. Among authors: yan n. Medicine (Baltimore). 2023 Jul 21;102(29):e33543. doi: 10.1097/MD.0000000000033543. Medicine (Baltimore). 2023. PMID: 37478263 Free PMC article.

6

Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single‑institution experience.

Yan N, Guo S, Zhang Z, Shen S, Li X. Yan N, et al. Oncol Lett. 2024 Jan 31;27(3):135. doi: 10.3892/ol.2024.14268. eCollection 2024 Mar. Oncol Lett. 2024. PMID: 38357477 Free PMC article.

7

Correction to: Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6.

Li M, Wang Q, Zhang X, Yan N, Li X. Li M, et al. Among authors: yan n. Cancer Cell Int. 2021 Jun 2;21(1):289. doi: 10.1186/s12935-021-01974-0. Cancer Cell Int. 2021. PMID: 34078381 Free PMC article. No abstract available.

8

Exosomal miR-126 blocks the development of non-small cell lung cancer through the inhibition of ITGA6.

Li M, Wang Q, Zhang X, Yan N, Li X. Li M, et al. Among authors: yan n. Cancer Cell Int. 2020 Dec 15;20(1):574. doi: 10.1186/s12935-020-01653-6. Cancer Cell Int. 2020. PMID: 33317527 Free PMC article.

9

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.

Yan N, Guo S, Zhang H, Zhang Z, Shen S, Li X. Yan N, et al. Front Oncol. 2022 Mar 31;12:863043. doi: 10.3389/fonc.2022.863043. eCollection 2022. Front Oncol. 2022. PMID: 35433454 Free PMC article. Review.

10

Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report.

Yan N, Huang S, Li L, Guo Q, Geng D, Zhang H, Guo S, Li X. Yan N, et al. Front Pharmacol. 2023 Jul 26;14:1256801. doi: 10.3389/fphar.2023.1256801. eCollection 2023. Front Pharmacol. 2023. PMID: 37576810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,652 results

Search Page

Filters